HOWL
HOWL
NASDAQ · Biotechnology

Werewolf Therapeutics Inc

$0.98
-0.01 (-0.90%)
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +4,014.3% upside
Low Target $26.90
Average Target $40.32
High Target $53.74
Current Price $0.98
Current
$0.98
Target
$40.32
$26.90 $40.32 avg $53.74
Scenario Analysis
Bear Case
$26.90
2,644.9%
Low target
Base Case
$40.32
+4,014.3%
Avg target
Bull Case
$53.74
+5,383.7%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$1.27
-22.8% from high
52-Week Low
$0.27
+263.0% from low
Target vs 52W High
$40.32
+3,074.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.2%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%